However, in vitro data indicating that S100B multimers act as complementary suppressors of Aβ42 oligomerization and aggregation, underpinning their potential neuroprotective role in AD, have also been reported, with the limitations of the mere in vitro approach [25]. The gene discussed is S100B; the disease is Alzheimer disease.